Assertio Therapeutics Stock In The News
| ASRT Stock | USD 0.98 0.03 2.97% |
Our overall analysis of Assertio Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Assertio Therapeutics. The specific impact of Assertio Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Assertio Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Assertio Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Assertio Therapeutics Backtesting and Assertio Therapeutics Hype Analysis. For more information on how to buy Assertio Stock please use our How to Invest in Assertio Therapeutics guide.
Assertio |
Assertio Therapeutics Today Top News and Investor Outlook
Assertio Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Assertio and other traded companies coverage with news coverage. We help investors stay connected with Assertio headlines for the 28th of November to make an informed investment decision based on correlating the impacts of news items on Assertio Stock performance. Please note that trading solely based on the Assertio Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Assertio Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Assertio earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Assertio Therapeutics that are available to investors today. That information is available publicly through Assertio media outlets and privately through word of mouth or via Assertio internal channels. However, regardless of the origin, that massive amount of Assertio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Assertio Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Assertio Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Assertio Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Assertio Therapeutics alpha.
Assertio Largest EPS Surprises
Earnings surprises can significantly impact Assertio Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-11 | 2024-09-30 | -0.04 | -0.03 | 0.01 | 25 | ||
2024-08-07 | 2024-06-30 | -0.03 | -0.04 | -0.01 | 33 | ||
2022-11-08 | 2022-09-30 | 0.07 | 0.08 | 0.01 | 14 | ||
2024-05-06 | 2024-03-31 | -0.03 | -0.05 | -0.02 | 66 | ||
2022-03-09 | 2021-12-31 | 0.12 | 0.1 | -0.02 | 16 | ||
2010-04-29 | 2010-03-31 | -0.32 | -0.28 | 0.04 | 12 |
Assertio Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Assertio Therapeutics Stock. Current markets are slightly bearish. About 58% of major world exchanges and indexes are down. See today's market update for more information.
21st of November 2024
Assertio Holdings, Inc. Director Heather L. Mason Buys 75,000 Shares at thelincolnianonline.com
18th of November 2024
Acquisition by Heather Mason of 75000 shares of Assertio Therapeutics at 0.8 subject to Ru... at MacroaxisInsider
15th of November 2024
Little Excitement Around Assertio Holdings, Inc.s Revenues As Shares Take 25 percent Pound... at simplywall.st
12th of November 2024
Assertio Holdings, Inc. Q3 2024 Earnings Call Transcript at insidermonkey.com
11th of November 2024
Assertio Reports Third Quarter 2024 Financial Results at globenewswire.com
8th of November 2024
Assertio Holdings Inc Q3 2024 Everything You Need to Know Ahead of Earnings at gurufocus.com
30th of October 2024
ASRT - Assertio Holdings, Inc. Latest Stock News Market Updates - StockTitan at news.google.com
9th of October 2024
Assertio Holdings Inc Q2 2024 Earnings Call Highlights Navigating Sales Challenges and ... at gurufocus.com
1st of October 2024
Disposition of 19404 shares by Sam Schlessinger of Assertio Therapeutics subject to Rule 1... at MacroaxisInsider
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Assertio Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Assertio Therapeutics' short interest history, or implied volatility extrapolated from Assertio Therapeutics options trading.
Additional Tools for Assertio Stock Analysis
When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.